Silicosis: New Challenges from an Old Inflammatory and Fibrotic Disease
Silicosis, an occupational lung disease that can be prevented, is still a significant public health concern in many countries, despite its considerably decreased incidence over the years. The latency period for silicosis ranges from a few years to several decades, depending on the duration and inten...
Main Authors: | Claudia-Mariana Handra, Irina-Luciana Gurzu, Marinela Chirila, Isabel Ghita |
---|---|
Format: | Article |
Language: | English |
Published: |
IMR Press
2023-05-01
|
Series: | Frontiers in Bioscience-Landmark |
Subjects: | |
Online Access: | https://www.imrpress.com/journal/FBL/28/5/10.31083/j.fbl2805096 |
Similar Items
-
From Basic Research to Clinical Practice: Considerations for Treatment Drugs for Silicosis
by: Rou Li, et al.
Published: (2023-05-01) -
New Insights into Pathomechanisms and Treatment Possibilities for Lung Silicosis
by: Jana Adamcakova, et al.
Published: (2021-04-01) -
A Novel N-Arylpyridone Compound Alleviates the Inflammatory and Fibrotic Reaction of Silicosis by Inhibiting the ASK1-p38 Pathway and Regulating Macrophage Polarization
by: Mingming Fan, et al.
Published: (2022-03-01) -
Addendum: A novel N-Arylpyridone compound alleviates the inflammatory and fibrotic reaction of silicosis by inhibiting the ASK1-p38 pathway and regulating macrophage polarization
by: Mingming Fan, et al.
Published: (2023-01-01) -
Corrigendum: A novel N-arylpyridone compound alleviates the inflammatory and fibrotic reaction of silicosis by inhibiting the ASK1-p38 pathway and regulating macrophage polarization
by: Mingming Fan, et al.
Published: (2023-01-01)